https://www.selleckchem.com/pr....oducts/(-)-Epigalloc
We also updated a recently published meta-analysis of trials to include the findings of this study. We included 159 randomized participants in the modified intention-to-treat analysis, with 80 allocated to receive vitamin K and 79 to receive placebo. Mean age was 66 years, 62 (39%) were female, and 87 (55%) had CKD stage 4. We found no differences in pulse wave velocity at 12 months, augmentation index at 12 months, BP, B-type natriuretic peptide, or physical function. The updated meta-analysis showed no effect of v
Like
Comment
Share
